[Study of a biological response modifier in the treatment of infections of the ORL region].
Hötzinger
H
H
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000628:therapy*; D002130:Calcium Phosphates / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005260:Female; D006020:Glycopeptides / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010038:Otorhinolaryngologic Diseases / Q000628:therapy*
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D002130:Calcium Phosphates; D006020:Glycopeptides; C038773:Immunoferon
Estudio de un modificador de la respuesta biológica, en el tratamiento de las infecciones de la esfera ORL.